Epigenetics, predictive signals of satiety and obesity

Published Date: 02 Mar 2023

Researchers seek to predict markers of the state of obesity, the risk of associated complications and the response to diet or bariatric surgery.

Read Full News

Latest News

GLP-1s a Viable Option to Treat, Prevent SUDs?

Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

Inpatient Glucose Testing Triples Postpartum Screening

Giving an inpatient oral glucose tolerance test before delivery discharge for women with gestational diabetes tripled the completion rate compared to postpartum testing.

Structure's Obesity Pill Shows Up to 16.3% Weight Loss in Study

Structure Therapeutics said on Monday its pill helped patients lose up to 16.3% of their weight, strengthening ⁠its bid to challenge Eli Lilly and Novo Nordisk in the...

Upcoming Guidance to Address GLP Drugs in Type 1 Diabetes

Off-label adjunctive use requires careful dosing, dose adjustments of insulin and other medications, and close monitoring.

Pancreatic Enzyme Replacement Therapy for GLP-1 Symptoms?

The therapy shows efficacy in improving diarrhea, abdominal pain in GLP-1, GLP-1/GIP-treated patients with diabetes and/or obesity in a small study.

Tight Glycemic Target in Gestational Diabetes Reduces Risks

Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.

Todays Updates

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

Long-acting injectable antipsychotics are linked to lower rehospitalization rates than oral antipsychotics in patients with bipolar I disorder, a study shows.

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

Todays Updates

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

Long-acting injectable antipsychotics are linked to lower rehospitalization rates than oral antipsychotics in patients with bipolar I disorder, a study shows.

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

Latest News

Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

Giving an inpatient oral glucose tolerance test before delivery discharge for women with gestational diabetes tripled the completion rate compared to postpartum testing.

Structure Therapeutics said on Monday its pill helped patients lose up to 16.3% of their weight, strengthening ⁠its bid to challenge Eli Lilly and Novo Nordisk in the...

Off-label adjunctive use requires careful dosing, dose adjustments of insulin and other medications, and close monitoring.

The therapy shows efficacy in improving diarrhea, abdominal pain in GLP-1, GLP-1/GIP-treated patients with diabetes and/or obesity in a small study.

Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.

News All Time

From Open Surgery to AI in Kidney Stone Care

Miniaturized percutaneous techniques, flexible ureteroscopy, and outpatient protocols have shortened hospital stays and improved recovery, reshaping quality-of-life outcomes for patients.

Early Introduction of Tirzepatide Yields T2D Benefits

Two-year data from Eli Lilly’s SURPASS-EARLY trial show reduced A1c, body weight, and cardiovascular risk factors.

West Virginia Can Ban Medicaid Coverage for Gender-affirming Surgery, US Court Rules

A U.S. appeals court on Tuesday upheld West Virginia's ban on Medicaid coverage for gender-affirming surgeries, the latest victory for Republican-led states seeking to curb...

Eli Lilly to Invest $3 Billion in China

Eli Lilly plans to invest $3 billion in China, which ⁠will help build production capacity for its experimental type-2 diabetes and obesity treatment orforglipron.

Majority of Papillary Thyroid Cancer Cases Are Overdiagnosis

Study finds up to 94% of papillary thyroid cancers in the past three decades were overdiagnosed, with stable mortality rates, despite soaring detection rates.

GLP-1s Effective for Migraine Management?

Real-world data suggest GLP-1 receptor agonists may reduce emergency care visits and the need for additional migraine treatments in adults with chronic migraine.

Parental Obesity Linked to Increased MASLD Risk in Offspring

Elevated prepregnancy BMI in either parent is linked to increased odds of offspring developing metabolic dysfunction-associated steatotic liver disease in early adulthood.

Bariatric Surgery Reduces Sleep Apnea Long Term

In adults with obesity, bariatric surgery is linked to a higher sleep apnea remission rate and fewer new cases of obstructive sleep apnea over 20 years than usual obesity care.

Predicting Early Weight Regain After Sleeve Gastrectomy

Lower preoperative BMI and suboptimal 12-month weight loss are linked to rapid weight regain within 2 years after sleeve gastrectomy.

Lindt Says Weight-loss Drugs Users Are Eating More Chocolate, Not Less

Chocolate sales are rising faster among U.S. users of GLP-1 weight-loss drugs ⁠than in the rest of the population, Swiss chocolatier Lindt & Spruengli said on Tuesday,...

When Lab Reference Values May Mislead Clinicians

Laboratory reference ranges reflect methods, populations, and policies, and experienced clinicians interpret them in context rather than applying fixed cutoffs theoretically.

Targeted Brain Tumour Drug Approved for NHS Scotland

Scotland has approved the targeted therapy vorasidenib for some low-grade brain tumours, while NICE in England continues to review its cost-effectiveness.

Novo and Hims to Sell Obesity Drugs Together as Feud Ends, Bloomberg News Reports

Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on ⁠Hims & Hers Health platform, bringing an end to a dispute between the ⁠two companies that escalated...

Women at Higher Risk for Smoking Relapse Than Men

Women face biological, hormonal, and psychosocial factors that complicate smoking cessation, prompting experts to call for sex-specific strategies to improve quit success.

How Policy and New Drugs Reshaped Obesity Treatment

The 2013 declaration of obesity as a chronic disease and the 2021 approval of semaglutide are associated with increased use of antiobesity medications, while bariatric surgery rates remain stable.

Self-Insulin Dosing Leads to Control in Gestational Diabetes

In individuals with gestational diabetes, patient-led insulin titration is linked to faster glycemic control and a lower risk for macrosomia than clinician-led approaches.

Recommended News For You

Decrease seen in in situ breast cancer since 2009

More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.

Stereotactic Radiation Linked to Better Brain Mets Outcomes

Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma

Obesity-related cancers are more likely in people who are obese in both healthy and unhealthy ways.

According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.

Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia

Recommended Articles For You

Revolutionizing Oncology: Pharmacometric Models in Personalized Cancer Drug Development 

Personalized Neoantigen Vaccines and the Promise of a Less Toxic Future in Pediatric Oncology 

Beyond the Battle: Navigating Life After Cancer 

Oncolytic Vaccinia Virus Immunotherapy: A New Frontier in GI Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

2.

Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.

3.

Could semaglutide be used to treat addiction in addition to obesity?

4.

Neural networks and label-free microscopy enable accurate detection of pancreatic tumors

5.

Q&A: Odds of surviving cancer drop drastically when credit score dips

1.

Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer

2.

Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy

3.

AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined

4.

What You Need To Know About Trametinib: A Miracle Cancer Treatment?

5.

Unlocking the Mystery of Leukemia: Exploring New Treatments and Hope for Patients

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

2.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III

4.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot